PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Arasi Pearia Anadachee

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs1 Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 8, 2026 · JOURNAL ARTICLE

Comparative efficacy and safety of Dual GIP/GLP1 agonists versus GLP1 receptor agonists for weight loss: A Scoping Review

Journal of Advances in Internal Medicine

Scoping review synthesizing comparative efficacy and safety data across multiple studies of dual GIP/GLP-1 versus GLP-1 agonists, demonstrating dual agonists superiority for weight loss with identified safety trade-offs.

Strong EvidencePharmacology and Obesity Treatment Kshitija Gajadhur Arasi Pearia Anadachee

Study details

DesignScoping review

InterventionDual GIP/GLP-1 agonists (including tirzepat…

ComparatorGLP-1 receptor agonists (including semaglut…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support